Key result
Attain Performa quadripolar LV leads linked to ~57% lower VT/VF rates versus bipolar leads.
Why the study?
Does the Attain Performa quadripolar left ventricular lead provide effective electrical performance and improve long-term clinical outcomes compared to standard bipolar leads in patients undergoing CRT-D implantation?
Cohort (n=336)
Yes
Does the Attain Performa quadripolar left ventricular lead provide effective electrical performance and improve long-term clinical outcomes compared to standard bipolar leads in patients undergoing CRT-D implantation?
Short-spaced quadripolar LV leads facilitate optimal basal/mid-ventricular CRT pacing with high stability and minimal phrenic nerve stimulation, while potentially reducing ventricular arrhythmias and pulmonary congestion compared to bipolar leads.
Answers are grounded in this paper and cite their sources.
May support quadripolar LV leads in CRT-D; hypothesis-generating for VT/VF reduction, needing RCTs.
AIM: To evaluate Attain Performa (Medtronic, Dublin, Ireland) quadripolar lead performance in clinical practice and, secondarily, to compare its long term clinical outcomes vs bipolar leads for left ventricular (LV) pacing. METHODS AND RESULTS: We retrospectively analyzed clinical, procedural and follow-up data of 215 patients implanted with a quadripolar lead. One hundred and twenty one patients implanted with bipolar lead were selected to compare long-term clinical outcomes. The quadripolar lead was implanted in the target vein in 196 patients (91%) without acute dislodgements. In 50% of patients the chosen final pacing configuration at implant would not have been available with bipolar leads. A dedicated quadripolar pacing vector was chosen more frequently when the LV tip location was apical than otherwise (65.6% vs 42.7%, p=0.003). After a median follow-up of 14 months, the LV pacing threshold was less than 2.5V at 0.4ms in 98 patients (90%) with a safety margin between phrenic nerve and LV pacing threshold >3V in 97 patients (89%). We observed a slight trend toward a lower risk of heart failure worsening and a lower incidence of ventricular arrhythmias and pulmonary congestion in patients implanted with quadripolar leads compared with the control group. CONCLUSION: Quadripolar leads improve the management of phrenic nerve stimulation at no trade-off with pacing threshold and lead stability. Quadripolar leads seems to be associated with a lower incidence of VT/VF and pulmonary congestion, when compared with bipolar leads, but further investigations are necessary to confirm that this positive effect is associated with better LV reverse remodeling.
No takes yet. Share an insight, caveat, or question.
Ziacchi et al. (2018) conducted a cohort in Symptomatic heart failure with prolonged QRS duration and impaired left ventricular systolic function undergoing CRT-D implantation (n=336). Attain Performa quadripolar left ventricular lead vs. Standard Medtronic passive fixation bipolar left ventricular leads (Attain Bipolar OTW or Attain Ability) was evaluated on Target vein implantation success without acute dislodgement and LV pacing threshold <2.5V at 0.4ms at 14-month follow-up. Attain Performa quadripolar LV leads achieved 91% target vein implantation without acute dislodgement, 90% pacing threshold <2.5V, and lower VT/VF than bipolar leads.
Synapse has enriched 10 related papers. Consider them for comparative context: